Your account is not claimed yet. You can sign up with ORCID to claim your account.

Daniel S Pilch

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

ACS chemical biology

ACS omega

Antibiotics (Basel, Switzerland)

Scientific reports

Rutgers Robert Wood Johnson Medical School

University of California San Francisco (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rutgers Robert Wood Johnson Medical School

United States

Professor :: Pharmacology

Education History

University of California San Francisco

United States

PHD :: Biophysics

Publications

Bin Lu, Qi Qiao, Elizabeth R Park, Yuxuan Wang, John A Gilleran, Matthew Pan, Daniel S Pilch, Xiang Wu, Jacques Y Roberge, Huizhou Fan
Acylpyrazoline-Based Third-Generation Selective Antichlamydial Compounds with Enhanced Potency. ACS omega 8 (7) (2023)
Eric Bryan, Edgar Ferrer-González, Hye Yeon Sagong, Junso Fujita, Lilly Mark, Malvika Kaul, Edmond J LaVoie, Hiroyoshi Matsumura, Daniel S Pilch
Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus . ACS chemical biology (2023)
Eric Bryan, Edgar Ferrer-González, Hye Yeon Sagong, Junso Fujita, Lilly Mark, Malvika Kaul, Edmond J LaVoie, Hiroyoshi Matsumura, Daniel S Pilch
Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus . ACS chemical biology 18 (3) (2023)
Bin Lu, Qi Qiao, Elizabeth R Park, Yuxuan Wang, John A Gilleran, Matthew Pan, Daniel S Pilch, Xiang Wu, Jacques Y Roberge, Huizhou Fan
Acylpyrazoline-Based Third-Generation Selective Antichlamydial Compounds with Enhanced Potency. ACS omega 8 (7) (2023)
Eric Bryan, Edgar Ferrer-González, Hye Yeon Sagong, Junso Fujita, Lilly Mark, Malvika Kaul, Edmond J LaVoie, Hiroyoshi Matsumura, Daniel S Pilch
Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus . ACS chemical biology 18 (3) (2023)
Eric J Bryan, Hye Yeon Sagong, Ajit K Parhi, Mark C Grier, Jacques Y Roberge, Edmond J LaVoie, Daniel S Pilch
TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Malvika Kaul, Edgar Ferrer-González, Lilly Mark, Ajit K Parhi, Edmond J LaVoie, Daniel S Pilch
Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant Staphylococcus aureus . Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 31 (10) (2022)
Edgar Ferrer-González, Junso Fujita, Takuya Yoshizawa, Julia M Nelson, Alyssa J Pilch, Elani Hillman, Mayuki Ozawa, Natsuko Kuroda, Hassan M Al-Tameemi, Jeffrey M Boyd, Edmond J LaVoie, Hiroyoshi Matsumura, Daniel S Pilch
Structure-Guided Design of a Fluorescent Probe for the Visualization of FtsZ in Clinically Important Gram-Positive and Gram-Negative Bacterial Pathogens. Scientific reports 9 (1) (2019)

Daniel S Pilch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel S Pilch